Quotient Sciences Recognized as a Winner of 2025 CDMO Leadership Awards
Read More1 - 5 of 154 results
Dr. Helen Baker, Director of Formulation Design, and Dr. Richard Castledine, Head of Drug Substance Operations, contribute to Pharmaceutical Technology's issue, 'Poor API Quality Threatens a Healthy Supply'.
Learn more
Thierry Van Nieuwenhove, CEO of Quotient Sciences, discusses the evolving landscape of Contract Development and Manufacturing Organizations (CDMOs).
Learn moreDr. Vanessa Zann, Vice President of Scientific Consulting, Translational Pharmaceutics® and Clinical Pharmacology USA, contributes to Drug Development & Delivery's special feature on bioavailability & solubility.
Learn moreAt DCAT 2025, Quotient Sciences showcased how using a fully integrated service provider can help optimize drug development. In a video interview held just prior to the event, Helen Baker, Director of Formulation Design, discussed the benefi...
Learn more
Investments made as part of a capital project to modernize the facility and increase capacity for high potency handling for drug product manufacturing
Learn more
